KWMG LLC’s MaxCyte MXCT Stock Holding History

KWMG LLC’s Portfolio MXCT Stock Details MXCT Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q3	$28.9K	Hold	25,833	–	–	﹤0.01%	155
2026 Q2	$31.8K	Hold	25,833	–	–	﹤0.01%	153
2026 Q1	$18.1K	Hold	25,833	–	–	﹤0.01%	147
2025 Q4	$40K	Hold	25,833	–	–	﹤0.01%	149
2025 Q3	$40.8K	Buy	25,833 +11,135	+76%	+$19.4K	﹤0.01%	150
2025 Q2	$32K	Hold	14,698	–	–	﹤0.01%	146
2025 Q1	$40.1K	Buy	+14,698	New	+$58K	﹤0.01%	143

Other funds holding MXCT

GAMMA Investing Foster City, California $2.96B AUM 34.38% 1-Year Est. Return

FFA

Farther Finance Advisors San Francisco, California $14.2B AUM 18.33% 1-Year Est. Return

KWMG LLC's MXCT Position: Q3 2026 in Review

KWMG LLC held its MaxCyte (MXCT) position steady in Q3 2026 at 25,833 shares worth $28.9K. The position accounts for ﹤0.01% of the portfolio, ranked #155.

KWMG LLC first reported a position in MXCT in Q1 2025 and has held it in 7 quarters since. The position peaked at $40.8K in Q3 2025. 3 funds tracked by Wall St. Rank hold MXCT as of Q3 2026.

KWMG LLC held 25,833 shares of MaxCyte worth $28.9K as of Q3 2026.
KWMG LLC left its MaxCyte share count unchanged in Q3 2026.
MaxCyte made up ﹤0.01% of KWMG LLC's portfolio in Q3 2026, its #155 holding.
KWMG LLC first reported a position in MaxCyte in Q1 2025 and has held it in 7 quarters since.
KWMG LLC's MaxCyte position peaked at $40.8K in Q3 2025.
3 funds tracked by Wall St. Rank held MaxCyte as of Q3 2026.

Based on KWMG LLC's 13F filing for Q3 2026, filed 7 Oct 2026.